• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients.

作者信息

Tayama M, O'Brien J S, Kishimoto Y

机构信息

University of California, School of Medicine, Department of Neurosciences, San Diego, La Jolla 92093-0634.

出版信息

J Mol Neurosci. 1992;3(4):171-5. doi: 10.1007/BF03380135.

DOI:10.1007/BF03380135
PMID:1389998
Abstract

Saposins are a group of small glycoproteins derived from a single precursor protein, prosaposin. Each of the four saposins are involved in lysosomal hydrolysis of various sphingolipids. Our recent investigations have shown that saposins accumulate in tissues of several lysosomal storage diseases patients, including those with Tay-Sachs disease and Gaucher disease. To obtain insight into the mechanism of accumulation and its pathological role, the subcellular distribution of saposins in brain from Tay-Sachs disease and in spleen of Gaucher disease were compared with that of GM2 ganglioside and glucocerebroside, respectively. In both Tay-Sachs brain and Gaucher spleen, saposins were found predominantly in light-density fractions while most of the GM2 ganglioside and glucocerebroside, respectively, were found in heavy-density fractions. These studies indicate that saposins that accumulate in these pathological tissues are not tightly associated with GM2 ganglioside or glucocerebroside.

摘要

相似文献

1
Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients.
J Mol Neurosci. 1992;3(4):171-5. doi: 10.1007/BF03380135.
2
Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.鞘脂激活蛋白(saposin蛋白)在溶酶体贮积症及其他疾病中的分布
Proc Natl Acad Sci U S A. 1990 May;87(9):3493-7. doi: 10.1073/pnas.87.9.3493.
3
Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient.
Eur J Biochem. 1993 Jul 1;215(1):171-9. doi: 10.1111/j.1432-1033.1993.tb18020.x.
4
[Disorders of sphingolipid activator proteins].
Nihon Rinsho. 1995 Dec;53(12):3025-7.
5
Sphingolipid hydrolase activator proteins and their precursors.
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1191-7. doi: 10.1016/0006-291x(89)92728-9.
6
Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.青少年GM2神经节苷脂沉积症(AMB变异型):无法通过激活蛋白激活己糖胺酶A。
Am J Hum Genet. 1983 Jul;35(4):551-64.
7
Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.膜结合神经节苷脂GM1的降解。由双(单酰甘油)磷酸酯以及激活蛋白SAP-B和GM2-AP刺激。
J Biol Chem. 2000 Nov 17;275(46):35814-9. doi: 10.1074/jbc.M006568200.
8
Interaction of GM2 activator protein with glycosphingolipids.GM2激活蛋白与鞘糖脂的相互作用。
J Biol Chem. 1997 Jan 31;272(5):2828-33. doi: 10.1074/jbc.272.5.2828.
9
Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.颗粒蛋白前体与氨基己糖苷酶 A 结合,改善泰萨二氏症 GM2 神经节苷脂蓄积和溶酶体贮积。
J Mol Med (Berl). 2018 Dec;96(12):1359-1373. doi: 10.1007/s00109-018-1703-0. Epub 2018 Oct 20.
10
Saposins: structure, function, distribution, and molecular genetics.鞘脂激活蛋白:结构、功能、分布及分子遗传学
J Lipid Res. 1992 Sep;33(9):1255-67.

引用本文的文献

1
RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.RNA 结合蛋白与额颞叶变性发病机制的关系。
Annu Rev Pathol. 2019 Jan 24;14:469-495. doi: 10.1146/annurev-pathmechdis-012418-012955. Epub 2018 Oct 24.
2
Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase.源自酰化蛋白的脂质硫酯在婴儿神经元蜡样脂褐质沉积症中蓄积:重组棕榈酰蛋白硫酯酶对淋巴母细胞缺陷的纠正。
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10046-50. doi: 10.1073/pnas.93.19.10046.
3
Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study.

本文引用的文献

1
Studies on yeast metabolism. I. Fractionation and microdetermination of cell carbohydrates.酵母代谢的研究。I. 细胞碳水化合物的分级分离与微量测定。
Biochem J. 1952 Jan;50(3):298-303. doi: 10.1042/bj0500298.
2
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
3
Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.唾液酸的定量测定。II. 比色间苯二酚 - 盐酸法。
神经元蜡样脂褐质沉积症中的鞘脂激活蛋白:一项免疫学研究。
Acta Neuropathol. 1995;89(5):391-8. doi: 10.1007/BF00307641.
Biochim Biophys Acta. 1957 Jun;24(3):604-11. doi: 10.1016/0006-3002(57)90254-8.
4
Protein activator (coglucosidase) for the hydrolysis of beta-glucosides.
Methods Enzymol. 1982;83:596-603. doi: 10.1016/0076-6879(82)83057-7.
5
Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.从1型GM1神经节苷脂贮积症患者肝脏中分离出的糖鞘脂水解蛋白激活剂的特性
Biochem Biophys Res Commun. 1982 Mar 30;105(2):745-51. doi: 10.1016/0006-291x(82)91497-8.
6
Turnover of the fatty acids of rat brain gangliosides, glycerophosphatides, cerebrosides, and sulfatides as a function of age.
J Lipid Res. 1965 Oct;6(4):525-31.
7
Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.高雪氏病:“酸性”葡萄糖苷酶缺乏及体外酶活性的恢复
Proc Natl Acad Sci U S A. 1971 Nov;68(11):2810-3. doi: 10.1073/pnas.68.11.2810.
8
Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids.一种用于糖脂酶促水解的非特异性激活蛋白的特性分析。
J Biol Chem. 1988 May 15;263(14):6588-91.
9
Mammalian glucocerebrosidase: implications for Gaucher's disease.
Lab Invest. 1988 Jan;58(1):5-25.
10
Saposin D: a sphingomyelinase activator.鞘脂激活蛋白D:一种鞘磷脂酶激活剂。
Biochem Biophys Res Commun. 1988 Oct 14;156(1):403-10. doi: 10.1016/s0006-291x(88)80855-6.